SCHEMBL21633725

SCHEMBL21633725

COC(=O)c1cnc(C)cc1CCNC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.44
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ATR Q13535 1/20 0.39
STK17B O94768 1/20 0.39
STK17A Q9UEE5 1/20 0.39
ALDH1A1 P00352 3/20 0.39
GFER P55789 1/20 0.39
CSNK1D P48730 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.37
IDO1 P14902 2/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MTNR1B P49286 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31528229 1.00 NQO2 (0.44) NQO2HTTNPSR1ATRSTK17B
SCHEMBL21633558 0.85 NQO2 (0.42) NQO2HTTNPSR1ATRSTK17B
SCHEMBL31528049 0.85 NQO2 (0.42) NQO2HTTNPSR1ATRSTK17B
SCHEMBL22349295 0.78 TDP1 (0.40) NPSR1STK17BSTK17ACSNK1DTDP1
SCHEMBL23854724 0.77 MTNR1B (0.48) NQO2HTTNPSR1STK17BSTK17A
SCHEMBL30570606 0.77 MTNR1B (0.48) NQO2HTTNPSR1STK17BSTK17A
SCHEMBL166559 0.76 LMNA (0.55) NQO2HTTALDH1A1IDO1MEN1
SCHEMBL23448796 0.75 GABRP (0.44) NPSR1ALDH1A1TDP1MAPTHPGD
SCHEMBL17688707 0.75 ATR (0.44) NQO2HTTNPSR1ATRSTK17B
SCHEMBL23854699 0.74 MTNR1B (0.41) NQO2HTTNPSR1STK17BSTK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US disclosed
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity SUMITOMO PHARMA CO. LTD. (JP) 2024-12-31 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity Sumitomo Pharma Co., Ltd. (JP) 2022-10-11 US disclosed
EP-3828182-A1 FUSED RING LACTAM DERIVATIVES Sumitomo Dainippon Pharma Co., Ltd. (JP) 2021-06-02 EP disclosed
CN-112424195-A Condensed lactam derivatives 大日本住友制药株式会社 2021-02-26 CN disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
WO-2020022237-A1 FUSED RING LACTAM DERIVATIVES 大日本住友製薬株式会社 2020-01-30 WO disclosed
WO-2020022237-A1 FUSED RING LACTAM DERIVATIVES 大日本住友製薬株式会社 2020-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 NQO2 679/4885HTT 934/4885NPSR1 1778/4885
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 NQO2 2230/4885HTT 842/4885NPSR1 28/4885
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity HTR5A, HTR1A, TPH1 NQO2 3080/4885HTT 357/4885NPSR1 25/4885
US-10745401-B2 Condensed lactam derivative PSEN1, GRIN1, HDAC1 NQO2 679/4885HTT 934/4885NPSR1 1778/4885
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity HTR1A, HTR5A, TPH1 NQO2 2230/4885HTT 842/4885NPSR1 28/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 NQO2 2230/4885HTT 842/4885NPSR1 28/4885
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 NQO2 679/4885HTT 934/4885NPSR1 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.